1. OS05.9.A Short-term fasting in glioma patients - Analysis of diet diaries and metabolic parameters of the ERGO2 trial. (9th September 2021) Authors: Voss, M; Wenger, K J; von Mettenheim, N; Bojunga, J; Vetter, M; Diehl, B; Gerlach, R; Ronellenfitsch, M W; Franz, K; Harter, P N; Hattingen, E; Steinbach, J P; Rödel, C; Rieger, J Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS06.2A Local immunotherapy of glioblastoma via AAV-mediated gene transfer of checkpoint inhibitors in combination with CAR-NK cells. (9th September 2021) Authors: Strecker, M I; Wlotzka, K; Strassheimer, F; Reul, J; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Buchholz, C J; Burger, M C Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo. (9th September 2021) Authors: Strassheimer, F; Strecker, M I; Alekseeva, T; Macas, J; Demes, M C; Mildenberger, I C; Tonn, T; Wild, P J; Sevenich, L; Reiss, Y; Harter, P N; Plate, K H; Wels, W S; Steinbach, J P; Burger, M C Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS6.5 ERGO2: A prospective randomized trial of a 9-day schedule of calorically restricted ketogenic diet and fasting or standard diet in addition to re-irradiation for malignant glioma. (6th September 2019) Authors: Voss, M; Wagner, M; von Mettenheim, N; Harter, P N; Wenger, K; Franz, K; Bojunga, J; Gerlach, R; Glatzel, M; Paulsen, F; Hattingen, E; Baehr, O; Ronellenfitsch, M W; Fokas, E; Imhoff, D; Steinbach, J P; Rödel, C; Rieger, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P01.101 Treatment and survival of patients with lower grade glioma according to the 2007 and the 2016 WHO classification: A retrospective analysis of 423 patients. (19th September 2018) Authors: Steidl, E; Zeiner, P; Wagner, M; Fokas, E; Forster, M; Ronellenfitsch, M; Steinbach, J P; Harter, P N; Bähr, O Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P04.21 Combination therapy of CAR-NK cells and anti-PD-1 antibody displays potent efficacy against late-stage Glioblastoma and induces protective antitumor immunity. (19th September 2018) Authors: Strassheimer, F; Zhang, C; Mildenberger, I C; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Burger, M C Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P04.24 MTOR signaling in glioma-associated microglia and macrophages. (19th September 2018) Authors: Zeiner, P S; Lorenz, N I; Burger, M; Luger, A L; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P04.47 Nrf2 mediates hypoxic tolerance in human glioblastoma cells. (19th September 2018) Authors: Lorenz, N I; Luger, A; Zeiner, P S; Engel, A L; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P04.50 Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using Tet-inducible systems. (19th September 2018) Authors: Sauer, B; Luger, A; Lorenz, N I; Engel, A L; Braun, Y; Voss, M; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P04.50 Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using Tet-inducible systems. (19th September 2018) Authors: Sauer, B; Luger, A; Lorenz, N I; Engel, A L; Braun, Y; Voss, M; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗